Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 3 studies | 23% ± 4% | |
non-classical monocyte | 3 studies | 20% ± 3% | |
endothelial cell | 3 studies | 21% ± 3% | |
epithelial cell | 3 studies | 22% ± 2% | |
macrophage | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of TAFAZZIN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2304.69 | 1445 / 1445 | 100% | 13.64 | 183 / 183 |
liver | 100% | 1517.04 | 226 / 226 | 100% | 12.58 | 406 / 406 |
skin | 100% | 2159.12 | 1809 / 1809 | 100% | 14.21 | 472 / 472 |
stomach | 100% | 1890.09 | 359 / 359 | 100% | 13.86 | 286 / 286 |
thymus | 100% | 3547.26 | 653 / 653 | 100% | 15.46 | 605 / 605 |
uterus | 100% | 3114.09 | 170 / 170 | 100% | 18.00 | 459 / 459 |
lung | 100% | 3220.16 | 578 / 578 | 100% | 15.15 | 1154 / 1155 |
kidney | 100% | 2605.12 | 89 / 89 | 100% | 13.40 | 899 / 901 |
intestine | 100% | 2767.18 | 966 / 966 | 100% | 15.67 | 525 / 527 |
adrenal gland | 100% | 1936.68 | 258 / 258 | 100% | 12.11 | 229 / 230 |
brain | 99% | 1949.48 | 2628 / 2642 | 100% | 18.21 | 705 / 705 |
pancreas | 100% | 1536.06 | 328 / 328 | 99% | 16.39 | 177 / 178 |
bladder | 100% | 2767.71 | 21 / 21 | 99% | 16.60 | 501 / 504 |
prostate | 100% | 3076.77 | 245 / 245 | 99% | 9.61 | 499 / 502 |
ovary | 100% | 2905.44 | 180 / 180 | 99% | 9.55 | 427 / 430 |
breast | 100% | 2660.32 | 459 / 459 | 98% | 11.57 | 1101 / 1118 |
adipose | 100% | 2597.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.62 | 29 / 29 |
spleen | 100% | 5724.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.94 | 1 / 1 |
heart | 100% | 2302.87 | 860 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2104.29 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1611.63 | 800 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 3197.21 | 925 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 11.15 | 79 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0030097 | Biological process | hemopoiesis |
GO_0048137 | Biological process | spermatocyte division |
GO_0007507 | Biological process | heart development |
GO_0007007 | Biological process | inner mitochondrial membrane organization |
GO_0006936 | Biological process | muscle contraction |
GO_0060048 | Biological process | cardiac muscle contraction |
GO_0003007 | Biological process | heart morphogenesis |
GO_0007005 | Biological process | mitochondrion organization |
GO_0042407 | Biological process | cristae formation |
GO_0035965 | Biological process | cardiolipin acyl-chain remodeling |
GO_0032048 | Biological process | cardiolipin metabolic process |
GO_0032981 | Biological process | mitochondrial respiratory chain complex I assembly |
GO_0032049 | Biological process | cardiolipin biosynthetic process |
GO_0048738 | Biological process | cardiac muscle tissue development |
GO_0042775 | Biological process | mitochondrial ATP synthesis coupled electron transport |
GO_0000423 | Biological process | mitophagy |
GO_1900210 | Biological process | positive regulation of cardiolipin metabolic process |
GO_2001171 | Biological process | positive regulation of ATP biosynthetic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0003841 | Molecular function | 1-acylglycerol-3-phosphate O-acyltransferase activity |
GO_0008374 | Molecular function | O-acyltransferase activity |
GO_0047184 | Molecular function | 1-acylglycerophosphocholine O-acyltransferase activity |
Gene name | TAFAZZIN |
Protein name | Tafazzin family protein Tafazzin (Taz) (EC 2.3.1.-) (Protein G4.5) Tafazzin, phospholipid-lysophospholipid transacylase |
Synonyms | TAZ G4.5 EFE2 |
Description | FUNCTION: Acyltransferase required to remodel newly synthesized phospholipid cardiolipin (1',3'-bis-[1,2-diacyl-sn-glycero-3-phospho]-glycerol or CL), a key component of the mitochondrial inner membrane, with tissue specific acyl chains necessary for adequate mitochondrial function . Its role in cellular physiology is to improve mitochondrial performance . CL is critical for the coassembly of lipids and proteins in mitochondrial membranes, for instance, remodeling of the acyl groups of CL in the mitochondrial inner membrane affects the assembly and stability of respiratory chain complex IV and its supercomplex forms (By similarity). Catalyzes the transacylation between phospholipids and lysophospholipids, with the highest rate being between phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) and CL. Catalyzes both 1-acyl-sn-glycero-3-phosphocholine (lysophosphatidylcholine or LPC) reacylation and PC-CL transacylation, that means, it exchanges acyl groups between CL and PC by a combination of forward and reverse transacylations. Also catalyzes transacylations between other phospholipids such as phosphatidylethanolamine (1,2-diacyl-sn-glycero-3-phosphoethanolamine or PE) and CL, between PC and PE, and between PC and phosphatidate (1,2-diacyl-sn-glycero-3-phosphate or PA), although at lower rate. Not regiospecific, it transfers acyl groups into any of the sn-1 and sn-2 positions of the monolysocardiolipin (MLCL), which is an important prerequisite for uniformity and symmetry in CL acyl distribution. Cannot transacylate dilysocardiolipin (DLCL), thus, the role of MLCL is limited to that of an acyl acceptor. CoA-independent, it can reshuffle molecular species within a single phospholipid class. Redistributes fatty acids between MLCL, CL, and other lipids, which prolongs the half-life of CL. Its action is completely reversible, which allows for cyclic changes, such as fission and fusion or bending and flattening of the membrane. Hence, by contributing to the flexibility of the lipid composition, it plays an important role in the dynamics of mitochondria membranes. Essential for the final stage of spermatogenesis, spermatid individualization (By similarity). Required for the initiation of mitophagy . Required to ensure progression of spermatocytes through meiosis (By similarity). Exon 7 of human tafazzin is essential for catalysis . .; FUNCTION: [Isoform 1]: Catalyzes the transacylation between lysophosphatidate (such as 1-acyl-sn-glycero-3-phosphate) and phosphatidylglycerol (1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)) . Contributes to cardiolipin (1',3'-bis-[1,2-diacyl-sn-glycero-3-phospho]-glycerol or CL) remodeling . .; FUNCTION: [Isoform 3]: Catalyzes the transacylation between lysophospholipids and phospholipids, and plays a fundamental role in cardiolipin (1',3'-bis-[1,2-diacyl-sn-glycero-3-phospho]-glycerol or CL) metabolism and remodeling. .; FUNCTION: [Isoform 5]: Catalytically inactive. .; FUNCTION: [Isoform 7]: Catalytically inactive. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . FUNCTION: Acyltransferase which is required to remodel newly synthesized phospholipid cardiolipin, a key component of the mitochondrial inner membrane. Required for the initiation of mitophagy. Required to ensure progression of spermatocytes through meiosis. . |
Accessions | ENST00000616020.5 ENST00000620808.4 ENST00000617701.5 A0A494C0V5 A0A0S2Z4E6 ENST00000651139.1 A0A0S2Z4F4 ENST00000652682.1 ENST00000652358.1 F6Y2X3 ENST00000652354.1 A0A494C0D2 ENST00000615986.4 A0A494C1C6 ENST00000369776.8 A0A0S2Z4K9 ENST00000601016.6 [Q16635-1] H7C2I9 A0A494C0C5 Q16635 A6XNE1 ENST00000439735.2 ENST00000475699.6 ENST00000612460.5 [Q16635-3] C9J699 A0A087WWD5 Q2VF39 ENST00000612012.5 [Q16635-5] ENST00000613002.4 [Q16635-7] A0A0S2Z4K0 A0A494C004 ENST00000479875.1 ENST00000652390.1 ENST00000652644.1 A0A494C1B0 ENST00000426231.5 A0A499FJ53 A0A494C141 |